The promising results on NF-κB obtained from molecular docking and MST encouraged us to verify in vitro if the two dimers can prevent NF-κB translocation to the nucleus and check the cytotoxic potential of these new compounds on leukemia cells. The gene discussed is NFKB1; the disease is leukemia.